NEUROLIEF Trademark

Trademark Overview


On Monday, May 2, 2022, a trademark application was filed for NEUROLIEF with the United States Patent and Trademark Office. The USPTO has given the NEUROLIEF trademark a serial number of 97391657. The federal status of this trademark filing is REGISTERED as of Tuesday, August 6, 2024. This trademark is owned by Neurolief Ltd.. The NEUROLIEF trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of medical devices, namely, medical devices for use in the treatment of chronic neurological and neuropsychiatric disorders; Providing online non-downloadable software for analysing signals measured from the head and brain for treating pain, anxiety, insomnia, migraine, depression and attention deficit hyperactivity disorder; Providing online non-downloadable software for providing user-related information to a practitioner for the treatment of chronic neurological and neuropsychiatric disorders; Providing online non-downloadable software for controlling an apparatus for treating pain, anxiety, insomnia, migraine, depression and attention deficit hyperactivity disorder by electric stimuli of the head and brain; Providing online non-downloadable computer software platforms for distributing electric stimuli of the head and brain treatment for treating pain, anxiety, insomnia, migraine, depression and attention deficit hyperactivity disorder
neurolief

General Information


Serial Number97391657
Word MarkNEUROLIEF
Filing DateMonday, May 2, 2022
Status700 - REGISTERED
Status DateTuesday, August 6, 2024
Registration Number7464903
Registration DateTuesday, August 6, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2024

Trademark Statements


Goods and ServicesResearch and development in the field of medical devices, namely, medical devices for use in the treatment of chronic neurological and neuropsychiatric disorders; Providing online non-downloadable software for analysing signals measured from the head and brain for treating pain, anxiety, insomnia, migraine, depression and attention deficit hyperactivity disorder; Providing online non-downloadable software for providing user-related information to a practitioner for the treatment of chronic neurological and neuropsychiatric disorders; Providing online non-downloadable software for controlling an apparatus for treating pain, anxiety, insomnia, migraine, depression and attention deficit hyperactivity disorder by electric stimuli of the head and brain; Providing online non-downloadable computer software platforms for distributing electric stimuli of the head and brain treatment for treating pain, anxiety, insomnia, migraine, depression and attention deficit hyperactivity disorder

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurolief Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNetanya 4250412
IL

Party NameNeurolief Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNetanya 4250412
IL

Party NameNeurolief Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNetanya 4250412
IL

Trademark Events


Event DateEvent Description
Thursday, May 5, 2022NEW APPLICATION ENTERED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Monday, August 1, 2022NON-FINAL ACTION WRITTEN
Monday, August 1, 2022NON-FINAL ACTION E-MAILED
Monday, August 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 1, 2023ASSIGNED TO LIE
Monday, May 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 7, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 7, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 5, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 5, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, December 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED